Elizabeth Bookbinder

Elizabeth Bookbinder has extensive work experience in the pharmaceutical industry. From 2023, they are currently working as the Director of Alliance Management at Meitheal Pharmaceuticals, Inc., where they are responsible for directing international partnerships to bring drug products to the U.S. market. Prior to this, they worked at Akorn Pharmaceutical from 2014 to 2023, where they held various roles. As the Director of Project Management, they oversaw and coordinated multiple drug launch projects, implemented a milestone review process to reduce submission errors, and successfully reduced FDA points for CRL letters. Elizabeth also served as the Associate Director of New Product Launch, partnering with functional leaders and coordinating strategic and operational activities to promote program execution and product launch. Additionally, they were the Manager of New Product Launches, responsible for building the division and ensuring cross-functional collaboration across key departments. Before joining Akorn, they worked at Rexam Healthcare from 2008 to 2014. In this role, they exceeded revenue targets as an Associate Global Marketing Manager and managed marketing strategies for medical device-focused business units. Elizabeth also worked as a Marketing Analyst and was responsible for market research and pricing analysis for product lines.

Elizabeth Bookbinder attended Northwood University, where they earned a Bachelor of Business Administration degree with a focus on Marketing and Management. The specific years of their education are not provided.